Eiji Takeda
Papers
1
Total Citations
5
H-Index
1
About
Eiji Takeda is a leading researcher in neurorehabilitation, with a focus on integrating advanced robotics into post-stroke care. His work centers on the clinical application of the Hybrid-Assisted Limb (HAL™), a wearable robotic exoskeleton designed to restore motor function. Takeda’s major contributions lie in combining botulinum neurotoxin (BoNT) injections with robotic therapy to address post-stroke spasticity—a primary cause of disability in survivors. In his most cited work (2021, 5 citations), he demonstrated that HAL™ enhances functional outcomes beyond what BoNT alone achieves, offering a novel, synergistic approach to spasticity management. Though his citation count is modest, his research is pioneering in its integration of robotics with pharmacological intervention, a niche yet rapidly growing field. Takeda’s work is particularly notable for its direct clinical relevance, providing evidence-based protocols that bridge the gap between assistive technology and patient rehabilitation. His findings are increasingly referenced in studies on robotic neurorehabilitation, positioning him as a key figure in the evolution of post-stroke therapy. For students and researchers, Takeda’s work exemplifies how targeted, interdisciplinary research can translate into tangible improvements in patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1